Tempus Ai Cl A (TEM)

$55.97 -2.58 (-4.41%)
Market Cap 10.64B
Revenue (ttm) 693.40M
Net Income (ttm) -705.81M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -101.79%
Debt to Equity Ratio 0.59
Volume 5,733,400
Avg Vol 4,625,344
Day's Range N/A - N/A
Shares Out 177.91M
Stochastic %K 10%
Beta 5.22
Analysts Sell
Price Target $87.92

Company Profile

Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services...

Industry: Health Information Services
Sector: Healthcare
Phone: 800 976 5448
Fax: 800 893 0276
Address:
600 West Chicago Avenue, Suite 510, Chicago, United States
GoldSilverStacker
GoldSilverStacker Feb. 4 at 3:20 AM
$TEM Nancy Pelosi brought me here
0 · Reply
JensenNVDA
JensenNVDA Feb. 4 at 1:30 AM
$BABA Brace yourself. The shorts are piling on because of the weakness in $NVDA $AVGO $TEM etc. At least we know they consider $BABA an AI Stock now. As usual, these short sellers will take their profits and it will spark a big short covering rally. Need one spark. One catalyst to reverse this all.
0 · Reply
gogo1927
gogo1927 Feb. 3 at 10:04 PM
$TEM I’m still holding 😄
0 · Reply
davidduong
davidduong Feb. 3 at 9:13 PM
$TEM back to $60 👌
0 · Reply
Stocktrader3546
Stocktrader3546 Feb. 3 at 9:11 PM
$TEM 50 when?
0 · Reply
davidduong
davidduong Feb. 3 at 8:50 PM
$TEM run 🙌
0 · Reply
Trader412pgh
Trader412pgh Feb. 3 at 6:39 PM
$TEM adding here 55.22 was buy target. I hope this doesn’t crash to 41. Only concern. Will continue to add equity. 60% pullback on the last 2 corrections on this. 🤯
0 · Reply
marketmaker79
marketmaker79 Feb. 3 at 6:36 PM
$TEM Collapsing fast
0 · Reply
THE_Monkey_Banana_Genius
THE_Monkey_Banana_Genius Feb. 3 at 5:59 PM
$TEM sold final lots for about flat
0 · Reply
davidduong
davidduong Feb. 3 at 5:33 PM
$TEM start new position here... fair price
0 · Reply
Latest News on TEM
Ambry Genetics Announces One Millionth Test Leveraging RNA to Improve Diagnostic Accuracy and Yield

Feb 2, 2026, 7:00 AM EST - 1 day ago

Ambry Genetics Announces One Millionth Test Leveraging RNA to Improve Diagnostic Accuracy and Yield

Tempus Reveals Its AI-Driven IPS Test More Accurately Predicts Immunotherapy Benefit Compared to Conventional Biomarkers

Jan 27, 2026, 8:30 AM EST - 7 days ago

Tempus Reveals Its AI-Driven IPS Test More Accurately Predicts Immunotherapy Benefit Compared to Conventional Biomarkers

Tempus Logix Launches AI-Powered Calculator to End Hidden Fees and Price Fluctuation in Auto Transport

Jan 26, 2026, 11:14 AM EST - 8 days ago

Tempus Logix Launches AI-Powered Calculator to End Hidden Fees and Price Fluctuation in Auto Transport

Tempus AI: Staying Bullish On Leading Healthcare AI Play

Jan 23, 2026, 9:44 AM EST - 11 days ago

Tempus AI: Staying Bullish On Leading Healthcare AI Play

Tempus AI Highlights Strong Growth At The J.P. Morgan Healthcare Conference

Jan 22, 2026, 8:00 AM EST - 12 days ago

Tempus AI Highlights Strong Growth At The J.P. Morgan Healthcare Conference

Tempus Announces the Launch of Paige Predict

Jan 21, 2026, 8:30 AM EST - 13 days ago

Tempus Announces the Launch of Paige Predict

Tempus AI, Inc. (TEM) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 12, 2026, 7:05 PM EST - 22 days ago

Tempus AI, Inc. (TEM) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Tempus and NYU Langone Health Announce Strategic Collaboration to Advance Precision Oncology

Jan 12, 2026, 8:30 AM EST - 22 days ago

Tempus and NYU Langone Health Announce Strategic Collaboration to Advance Precision Oncology

Here's why the Tempus AI stock may surge 47% soon

Jan 12, 2026, 8:00 AM EST - 22 days ago

Here's why the Tempus AI stock may surge 47% soon

Northwestern Medicine Selects Tempus to Expand Genomic Testing

Jan 12, 2026, 7:00 AM EST - 22 days ago

Northwestern Medicine Selects Tempus to Expand Genomic Testing

Stock Market Today: Dow Jones, S&P 500 Futures Tumble As DOJ Serves Federal Reserve—Vistra, Tempus AI, Alibaba In Focus

Jan 12, 2026, 5:33 AM EST - 22 days ago

Stock Market Today: Dow Jones, S&P 500 Futures Tumble As DOJ Serves Federal Reserve—Vistra, Tempus AI, Alibaba In Focus

BABA IVV SPXL SPY SSO UPRO VOO

Tempus Achieves Record Total Contract Value Exceeding $1.1 Billion

Jan 11, 2026, 5:30 PM EST - 23 days ago

Tempus Achieves Record Total Contract Value Exceeding $1.1 Billion

Tempus Announces Preliminary Fourth Quarter and Full Year 2025 Results

Jan 11, 2026, 5:00 PM EST - 23 days ago

Tempus Announces Preliminary Fourth Quarter and Full Year 2025 Results

Tempus Announces Eight Abstracts Accepted for Presentation at the 2026 ASCO® Gastrointestinal Cancers Symposium

Jan 8, 2026, 8:30 AM EST - 26 days ago

Tempus Announces Eight Abstracts Accepted for Presentation at the 2026 ASCO® Gastrointestinal Cancers Symposium

Rune Labs Taps Tempus Exec as New CEO to Expand AI-Enabled Neurology Care

Jan 8, 2026, 8:15 AM EST - 26 days ago

Rune Labs Taps Tempus Exec as New CEO to Expand AI-Enabled Neurology Care

Tempus to Present at 44th Annual J.P. Morgan Healthcare Conference

Jan 6, 2026, 8:30 AM EST - 4 weeks ago

Tempus to Present at 44th Annual J.P. Morgan Healthcare Conference

Tempus AI: A Healthcare Hyper-Growth Opportunity For The Risk Tolerant

Dec 18, 2025, 7:05 AM EST - 6 weeks ago

Tempus AI: A Healthcare Hyper-Growth Opportunity For The Risk Tolerant

Top 3 Health Care Stocks You'll Regret Missing This Quarter

Dec 18, 2025, 7:00 AM EST - 6 weeks ago

Top 3 Health Care Stocks You'll Regret Missing This Quarter

INSM LEGN

Tempus AI: Plenty Of Growth Catalysts Ahead, Grab It While It's Down

Dec 16, 2025, 10:13 AM EST - 7 weeks ago

Tempus AI: Plenty Of Growth Catalysts Ahead, Grab It While It's Down

Tempus Announces Ten Abstracts Accepted for Presentation at the 2025 San Antonio Breast Cancer Symposium

Dec 9, 2025, 8:30 AM EST - 2 months ago

Tempus Announces Ten Abstracts Accepted for Presentation at the 2025 San Antonio Breast Cancer Symposium

Tempus AI, Inc. (TEM) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

Dec 3, 2025, 12:53 PM EST - 2 months ago

Tempus AI, Inc. (TEM) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

Tempus to Participate in the Piper Sandler 37th Annual Healthcare Conference

Nov 18, 2025, 8:30 AM EST - 2 months ago

Tempus to Participate in the Piper Sandler 37th Annual Healthcare Conference

Tempus AI: Opportunity To Build Position

Nov 15, 2025, 10:00 AM EST - 2 months ago

Tempus AI: Opportunity To Build Position

Tempus and IFLI Announce Study to Advance Follicular Lymphoma Research

Nov 14, 2025, 8:30 AM EST - 2 months ago

Tempus and IFLI Announce Study to Advance Follicular Lymphoma Research

Tempus AI, Inc. (TEM) Presents at Stifel 2025 Healthcare Conference Transcript

Nov 13, 2025, 12:11 PM EST - 2 months ago

Tempus AI, Inc. (TEM) Presents at Stifel 2025 Healthcare Conference Transcript

Tempus AI: Great Buying Opportunity On Recent Weakness

Nov 13, 2025, 9:59 AM EST - 2 months ago

Tempus AI: Great Buying Opportunity On Recent Weakness

Tempus AI: A Good Bet For The Future Of Health Care

Nov 12, 2025, 5:34 PM EST - 2 months ago

Tempus AI: A Good Bet For The Future Of Health Care

Tempus AI: First Positive EBITDA, Huge TAM - Yet The Stock Isn't A Buy

Nov 10, 2025, 9:55 PM EST - 3 months ago

Tempus AI: First Positive EBITDA, Huge TAM - Yet The Stock Isn't A Buy

Tempus AI Growth Outlook Boosted By Higher ASPs, Pharma Contracts, Analyst Says

Nov 5, 2025, 1:00 PM EST - 3 months ago

Tempus AI Growth Outlook Boosted By Higher ASPs, Pharma Contracts, Analyst Says

Tempus Announces Six Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer Annual Meeting 2025

Nov 5, 2025, 8:30 AM EST - 3 months ago

Tempus Announces Six Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer Annual Meeting 2025

Tempus AI, Inc. (TEM) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 7:06 PM EST - 3 months ago

Tempus AI, Inc. (TEM) Q3 2025 Earnings Call Transcript

Tempus Reports Third Quarter 2025 Results

Nov 4, 2025, 4:01 PM EST - 3 months ago

Tempus Reports Third Quarter 2025 Results

Tempus to Participate in the Stifel 2025 Healthcare Conference

Oct 28, 2025, 8:30 AM EDT - 3 months ago

Tempus to Participate in the Stifel 2025 Healthcare Conference

Tempus to Report Third Quarter 2025 Financial Results on November 4

Oct 21, 2025, 8:30 AM EDT - 3 months ago

Tempus to Report Third Quarter 2025 Financial Results on November 4

Ambry Genetics Announces 10-Year Study in Genetics in Medicine Highlighting the Impact of Proactive Exome Reanalysis for Healthcare Equity

Oct 20, 2025, 9:00 AM EDT - 3 months ago

Ambry Genetics Announces 10-Year Study in Genetics in Medicine Highlighting the Impact of Proactive Exome Reanalysis for Healthcare Equity

Tempus Announces Collaboration with Whitehawk Therapeutics to Advance Biomarker-Driven Oncology Research

Oct 16, 2025, 8:30 AM EDT - 3 months ago

Tempus Announces Collaboration with Whitehawk Therapeutics to Advance Biomarker-Driven Oncology Research

WHWK

Tempus Announces Six Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2025

Oct 15, 2025, 8:30 AM EDT - 3 months ago

Tempus Announces Six Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2025

Tempus Selected by ARPA-H to Provide CRO and Testing Services for the ADAPT Program, Advancing Precision Cancer Therapy

Oct 9, 2025, 8:30 AM EDT - 4 months ago

Tempus Selected by ARPA-H to Provide CRO and Testing Services for the ADAPT Program, Advancing Precision Cancer Therapy

Tempus AI's $100 Breakout — Billionaire Cliff Asness Reaps 60% Windfall

Oct 9, 2025, 8:24 AM EDT - 4 months ago

Tempus AI's $100 Breakout — Billionaire Cliff Asness Reaps 60% Windfall

Ambry Genetics Announces Improved EHR-Integrated Breast Cancer Risk Assessment Solution with Upgraded Tyrer-Cuzick Scoring Approach Incorporating Breast Density

Oct 1, 2025, 12:24 PM EDT - 4 months ago

Ambry Genetics Announces Improved EHR-Integrated Breast Cancer Risk Assessment Solution with Upgraded Tyrer-Cuzick Scoring Approach Incorporating Breast Density

Overlooked Stock: TEM Taps All-Time High on FDA Clearance

Sep 22, 2025, 4:30 PM EDT - 4 months ago

Overlooked Stock: TEM Taps All-Time High on FDA Clearance

Tempus Receives U.S. FDA 510(k) Clearance for Tempus xR IVD, its RNA NGS In Vitro Diagnostic Device

Sep 22, 2025, 8:30 AM EDT - 4 months ago

Tempus Receives U.S. FDA 510(k) Clearance for Tempus xR IVD, its RNA NGS In Vitro Diagnostic Device

Renalytix Announces Collaboration with Tempus to Advance Intelligent Risk Assessment in Diabetic Kidney Disease

Sep 15, 2025, 8:00 AM EDT - 5 months ago

Renalytix Announces Collaboration with Tempus to Advance Intelligent Risk Assessment in Diabetic Kidney Disease

Tempus AI stock is cheap as Murrey Math Lines points to more gains

Sep 12, 2025, 1:09 PM EDT - 5 months ago

Tempus AI stock is cheap as Murrey Math Lines points to more gains

Tempus AI: Is TEM Stock A 10x Growth Story?

Sep 12, 2025, 10:05 AM EDT - 5 months ago

Tempus AI: Is TEM Stock A 10x Growth Story?

Tempus AI Gains FDA Clearance For Updated Pixel To Boost Accuracy And Efficiency In Cardiac Imaging

Sep 11, 2025, 1:58 PM EDT - 5 months ago

Tempus AI Gains FDA Clearance For Updated Pixel To Boost Accuracy And Efficiency In Cardiac Imaging

Tempus Receives U.S. FDA Special 510(k) Clearance for Updated Tempus Pixel Device

Sep 11, 2025, 8:30 AM EDT - 5 months ago

Tempus Receives U.S. FDA Special 510(k) Clearance for Updated Tempus Pixel Device

Tempus Announces New Study in JCO Precision Oncology Validating PurIST® Algorithm for Enhanced Therapy Selection in Pancreatic Cancer

Sep 9, 2025, 8:30 AM EDT - 5 months ago

Tempus Announces New Study in JCO Precision Oncology Validating PurIST® Algorithm for Enhanced Therapy Selection in Pancreatic Cancer

Tempus AI, Inc. (TEM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Sep 8, 2025, 4:25 PM EDT - 5 months ago

Tempus AI, Inc. (TEM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

After An Odd Start, Tempus AI Is Making A Beeline To The Good End Of The AI Rainbow

Sep 8, 2025, 10:58 AM EDT - 5 months ago

After An Odd Start, Tempus AI Is Making A Beeline To The Good End Of The AI Rainbow

GoldSilverStacker
GoldSilverStacker Feb. 4 at 3:20 AM
$TEM Nancy Pelosi brought me here
0 · Reply
JensenNVDA
JensenNVDA Feb. 4 at 1:30 AM
$BABA Brace yourself. The shorts are piling on because of the weakness in $NVDA $AVGO $TEM etc. At least we know they consider $BABA an AI Stock now. As usual, these short sellers will take their profits and it will spark a big short covering rally. Need one spark. One catalyst to reverse this all.
0 · Reply
gogo1927
gogo1927 Feb. 3 at 10:04 PM
$TEM I’m still holding 😄
0 · Reply
davidduong
davidduong Feb. 3 at 9:13 PM
$TEM back to $60 👌
0 · Reply
Stocktrader3546
Stocktrader3546 Feb. 3 at 9:11 PM
$TEM 50 when?
0 · Reply
davidduong
davidduong Feb. 3 at 8:50 PM
$TEM run 🙌
0 · Reply
Trader412pgh
Trader412pgh Feb. 3 at 6:39 PM
$TEM adding here 55.22 was buy target. I hope this doesn’t crash to 41. Only concern. Will continue to add equity. 60% pullback on the last 2 corrections on this. 🤯
0 · Reply
marketmaker79
marketmaker79 Feb. 3 at 6:36 PM
$TEM Collapsing fast
0 · Reply
THE_Monkey_Banana_Genius
THE_Monkey_Banana_Genius Feb. 3 at 5:59 PM
$TEM sold final lots for about flat
0 · Reply
davidduong
davidduong Feb. 3 at 5:33 PM
$TEM start new position here... fair price
0 · Reply
shortking
shortking Feb. 3 at 4:49 PM
$TEM You have to wait till Nancy Pelosi friends take over Congress next year. Till then it is dead money…
1 · Reply
NeverPop
NeverPop Feb. 3 at 3:55 PM
$TEM literally an ATM for shorts. To easy for them. Annoying
0 · Reply
Chucko22
Chucko22 Feb. 3 at 3:01 PM
$TEM Cathy Wood strikes again
1 · Reply
bobross70
bobross70 Feb. 3 at 2:53 PM
$TEM 53 up next piece of shit
1 · Reply
RobotMumba100
RobotMumba100 Feb. 3 at 2:50 PM
$TEM https://x.com/TempusAI/status/2016927381823406418?s=20
0 · Reply
RobotMumba100
RobotMumba100 Feb. 3 at 2:48 PM
$TEM https://x.com/TempusAI/status/2018421100346999256?s=20
0 · Reply
RobotMumba100
RobotMumba100 Feb. 3 at 2:48 PM
$TEM ERIC....drop a news! 100-150$ end 2026! https://www.businesswire.com/news/home/20260202968713/en/Ambry-Genetics-Announces-One-Millionth-Test-Leveraging-RNA-to-Improve-Diagnostic-Accuracy-and-Yield
0 · Reply
NeverPop
NeverPop Feb. 3 at 2:47 PM
$TEM very strong to the downside. Haven’t seen a clear downtrend like this in stock like this in awhile. Maybe Netflix like
1 · Reply
ajsuff
ajsuff Feb. 3 at 11:45 AM
$TEM We need one of the +$5.00 days. We are due to test the $74 high from a few weeks ago.
0 · Reply
RNASequencing
RNASequencing Feb. 3 at 5:55 AM
$TEM lol bags getting heavy
0 · Reply
shortking
shortking Feb. 2 at 8:49 PM
$TEM SELL THE DAMN COMPANY…
1 · Reply
NeverPop
NeverPop Feb. 2 at 7:31 PM
$TEM oh yeah flipping short. So easy here. No one wants it
0 · Reply